Every patient breathes differently.
This can cause large variations in the amount of drug inhaled and may lead to unsuccessful treatment with conventional inhalation devices. Special electronics and sensors monitor how the patient is breathing throughout the treatment. This enables the AAD device to adapt the production of aerosol on a breath by breath basis in response to changes in the patients breathing. This enables consideration of e-health applications and can add value to clinical trials. Profile Therapeutics has a broad and innovative product range that is commercially available.